Blodgett Wealth Advisors’s CVS Health CVS Stock Holding History

Blodgett Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,965	Closed	-$201K	–	63
2025 Q1	$201K	Buy	+2,965	New	+$177K	0.17%	59
2024 Q4	–	Sell	-6,525	Closed	-$410K	–	60
2024 Q3	$410K	Sell	6,525 -550	-8%	-$32.1K	0.35%	37
2024 Q2	$418K	Sell	7,075 -666	-9%	-$41.7K	0.35%	34
2024 Q1	$617K	Sell	7,741 -302	-4%	-$23.1K	0.56%	28
2023 Q4	$635K	Sell	8,043 -5,152	-39%	-$367K	0.65%	26
2023 Q3	$921K	Sell	13,195 -1,273	-9%	-$90.2K	1.01%	22
2023 Q2	$1M	Hold	14,468	–	–	1.04%	21
2023 Q1	$1.08M	Hold	14,468	–	–	1.24%	20
2022 Q4	$1.35M	Hold	14,468	–	–	1.64%	17
2022 Q3	$1.38M	Buy	14,468 +108	+0.8%	+$10.7K	1.65%	16
2022 Q2	$1.33M	Buy	14,360 +452	+3%	+$44.1K	1.46%	18
2022 Q1	$1.41M	Buy	13,908 +663	+5%	+$69.7K	1.17%	21
2021 Q4	$1.37M	Buy	+13,245	New	+$1.22M	1.06%	23

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Blodgett Wealth Advisors's CVS Position: Q2 2025 in Review

Blodgett Wealth Advisors sold out of CVS Health (CVS) in Q2 2025, closing a stake of 2,965 shares — an estimated $201K sold.

Blodgett Wealth Advisors first reported a position in CVS in Q4 2021 and held it in 13 quarters. The position peaked at $1.41M in Q1 2022. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

Blodgett Wealth Advisors reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
Blodgett Wealth Advisors sold 2,965 CVS Health shares in Q2 2025, an estimated $201K.
Blodgett Wealth Advisors first reported a position in CVS Health in Q4 2021 and held it in 13 quarters.
Blodgett Wealth Advisors's CVS Health position peaked at $1.41M in Q1 2022.
1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Blodgett Wealth Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.